Law360, Wilmington (August 28, 2012, 8:52 PM ET) -- Goldman Sachs & Co. on Monday denied the allegation that its advice to Amerigroup Corp. on the health insurer's $4.9 billion merger with WellPoint Inc. was tainted by a conflict of interest, saying a shareholder suit mischaracterizes the derivative deal allegedly behind the conflict.
On Aug. 16, two pension fund shareholders hit Amerigroup's board and Goldman with a class action in Delaware Chancery Court claiming the defendants snubbed other potential buyers in favor of WellPoint to suit their own interests. Goldman, Amerigroup's financial adviser, allegedly stood...
Goldman Denies Conflict In $5B Amerigroup-WellPoint Deal
To view the full article, take a free trial now.
